- Innovative Molecules GmbH
Innovative Molecules Completes Enrollment of Phase 1b Clinical Trial of IM-250
Munich (OTE) - Innovative Molecules GmbH Announces Completion of Phase 1b Enrollment for IM-250 in Genital Herpes Clinical Trial
- 16.06.2025, 13:42:33
- /
- OTE0001